This country profile provides an overview of Angola’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage increased from 1% in 2018 to 11% in 2019.
Angola does not require mass treatment for blinding trachoma.
Treatment coverage decreased from 25% in 2018 to 14% in 2019.
Treatment coverage decreased from 51% in 2018 to 27% in 2019.
Treatment coverage decreased from 20% in 2018 to 12% in 2019.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Angola.